mTOR Co-Targeting in Cetuximab Resistance in Head and Neck Cancers Harboring PIK3CA and RAS Mutations-Reference-Cited by-同舟云学术

mTOR Co-Targeting in Cetuximab Resistance in Head and Neck Cancers Harboring PIK3CA and RAS Mutations

Published:2014-08-05 Issue:9 Volume:106 Page:
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Wang Zhiyong,Martin Daniel,Molinolo Alfredo A.,Patel Vyomesh,Iglesias-Bartolome Ramiro,Sol Degese Maria,Vitale-Cross Lynn,Chen Qianming,Gutkind J. Silvio

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/106/9/dju215/17313515/dju215.pdf

Reference60 articles.

1. Elevated Levels of Transforming Growth Factor a and Epidermal Growth Factor Receptor Messenger RNA Are Early Markers of Carcinogenesis in Head and Neck Cancer;Grandis;Cancer Res,1993

2. Epidermal growth factor receptor biology in head and neck cancer;Kalyankrishna;J Clin Oncol,2006

3. Levels of TGF-alfa and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival;Grandis;J Natl Cancer Inst,1998

4. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas;Chung;J Clin Oncol,2006

5. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells;Grandis;Oncogene,1997

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC;Cancer Research Communications;2024-07-01

2. Interplay of p62-mTORC1 and EGFR signaling promotes cisplatin resistance in oral cancer;Heliyon;2024-03

3. Immune escape of head and neck cancer mediated by the impaired MHC-I antigen presentation pathway;Oncogene;2024-01-04

4. New insights into RAS in head and neck cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

5. A kinome-wide synthetic lethal CRISPR/Cas9 screen reveals that mTOR inhibition prevents adaptive resistance to CDK4/CDK6 blockade in HNSCC;2023-08-07